GSK3B and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: In PaCa, it has been reported that inhibiting GSK3β activity with inhibitors or RNAi can preferentially attenuate the survival and proliferation of tumor cells and induce them to undergo apoptosis [30,31].